Radu-George Bolborici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Radu-George Bolborici has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alexandru Stan
Clinical Emergency Hospital for Children, 400370 Cluj-Napoca, Romania
1 shared publication - Alexandru-Florin Ene
Campus Research Institute, Politehnica University Bucharest, 060042 Bucharest, Romania
1 shared publication - Ana Neacsu Nicolae
Campus Research Institute, Politehnica University Bucharest, 060042 Bucharest, Romania
1 shared publication - Emanuela-Gabriela Hărăguș-Hațegan
Clinical Hospital for Infectious Diseases, 400348 Cluj-Napoca, Romania
1 shared publication - Ioan-Andrei Bârsan
Department of Computer Science, University of Toronto, Toronto, ON M5S 2E4, Canada
1 shared publication - Mara-Simina Olinic
Clinical Hospital for Infectious Diseases, 400348 Cluj-Napoca, Romania
1 shared publication
Latest Publications
- Open Access
- 27 October 2026
- Published by MDPI AG in Informatics
- Vol. 13 (11) , 180
GOBLIN: Prototype Architecture and Prospective Validation Roadmap for Clinician-Supervised Management of Auditory Verbal Hallucinations
Auditory verbal hallucinations are one of the most common symptoms in schizophrenia, contributing substantially to distress, functional impairment, and relapse risk. Existing therapeutic approaches, including pharmacological treatment and structured psychotherapies such as cognitive behavioral therapy for psychosis and AVATAR therapy, show promising clinical outcomes. However, scalability remains limited due to resource intensity and reliance on specialized personnel. Against this background, we describe the rationale, prototype architecture, and prospective validation roadmap for GOBLIN—a digital platform prototype combining personalized voice conversion, webcam-based eye-tracking, and large-language-model-assisted clinical documentation and decision support. The platform is intended to support clinician-supervised therapeutic workflows and between-visit monitoring following prospective validation. GOBLIN is intended to investigate whether an integrated digital workflow could address key limitations of current care models in schizophrenia and psychotic disorders, including fragmented follow-up, limited responsiveness to rapid symptom changes, and lack of scalable intervention tools. Our conceptual prototype is the first step toward leveraging the potential of digital, AI-driven platforms to complement existing treatment modalities and improve long-term management of psychosis-related symptoms. The system’s modules are intended for clinician-supervised research workflows and remain investigational. This manuscript does not report completed clinical validation, therapeutic efficacy, diagnostic performance, relapse-prediction performance, or validated safety outcomes. Such capabilities remain to be evaluated prospectively through staged technical, usability, safety, and clinical studies before clinical implementation can be considered.
- 27 October 2026
- Published by MDPI AG in Informatics
- Vol. 13 (11) , 180
Open AccessGOBLIN: Prototype Architecture and Prospective Validation Roadmap for Clinician-Supervised Management of Auditory Verbal Hallucinations
Auditory verbal hallucinations are one of the most common symptoms in schizophrenia, contributing substantially to distress, functional impairment, and relapse risk. Existing therapeutic approaches, including pharmacological treatment and structured psychotherapies such as cognitive behavioral therapy for psychosis and AVATAR therapy, show promising clinical outcomes. However, scalability remains limited due to resource intensity and reliance on specialized personnel. Against this background, we describe the rationale, prototype architecture, and prospective validation roadmap for GOBLIN—a digital platform prototype combining personalized voice conversion, webcam-based eye-tracking, and large-language-model-assisted clinical documentation and decision support. The platform is intended to support clinician-supervised therapeutic workflows and between-visit monitoring following prospective validation. GOBLIN is intended to investigate whether an integrated digital workflow could address key limitations of current care models in schizophrenia and psychotic disorders, including fragmented follow-up, limited responsiveness to rapid symptom changes, and lack of scalable intervention tools. Our conceptual prototype is the first step toward leveraging the potential of digital, AI-driven platforms to complement existing treatment modalities and improve long-term management of psychosis-related symptoms. The system’s modules are intended for clinician-supervised research workflows and remain investigational. This manuscript does not report completed clinical validation, therapeutic efficacy, diagnostic performance, relapse-prediction performance, or validated safety outcomes. Such capabilities remain to be evaluated prospectively through staged technical, usability, safety, and clinical studies before clinical implementation can be considered.